Skip to content
DraconiticResearch
Search Sources API
190,332 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BYMicrobiology (Reading, England)

In vitro and in vivo functional roles of three region 1 promoters in Escherichia coli K1 capsule gene cluster.

  1. 1Department of Clinical Laboratory Science, College of Applied Medical Science, King Saud University, P. O. Box 10219, Riyadh 11433, Kingdom of Saudi Arabia.
  2. 2School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Abstract

Capsular polysaccharides are key virulence determinants in extraintestinal pathogenic Escherichia coli, protecting bacteria from host immune defences while modulating interactions with host tissues. In group 2 capsule gene clusters, transcription of region 1 genes required for capsule export is controlled by a complex regulatory region (PR1) containing three tandem promoters (PR1-1, PR1-2 and PR1-3).In this study, targeted mutations were introduced into the -10 elements of each PR1 promoter in the uropathogenic strain UTI89. Transcriptional output from the PR1 region was assessed using a chromosomal PR1-lacZ fusion, and capsule expression was evaluated by K1 bacteriophage sensitivity assays, flow cytometry and immunofluorescence microscopy. Growth in Lysogeny Broth medium demonstrated that all three promoters contributed to capsule expression in vitro, with expression from both PR1-2 and PR1-3 being dependent on a functional upstream PR1-1.In contrast, infection of PD07i bladder epithelial cells revealed a distinct regulatory pattern in which, following invasion, intracellular capsule expression was restored in the absence of PR1-1 and PR1-2, indicating that PR1-3 was sufficient for capsule induction within bladder cells. The presence of a predicted binding site for the oxygen-responsive regulator fumarate and nitrate reduction regulatory protein near PR1-3 suggests a possible mechanism for intracellular activation of PR1-3 under microaerobic host conditions in the absence of a functional PR1-1 promoter.Together, these findings reveal a niche-dependent, multi-promoter regulatory architecture that enables adaptive control of capsule expression during infection.

Related

  1. Effects of a community-based intervention bundle on household transmission of extended spectrum β-lactamase-producing Escherichia coli in rural Burkina Faso to target community-level drivers of antimicrobial resistance in sub-Saharan Africa: a cluster-randomised trial
    Raneem Aizouk, Yougbaré Sibidou, Daniel Valia +32
    The Lancet MicrobePeer-reviewedCC BY 4.0Full textGeneral biologyEpidemiology & public healthHAL
  2. Cross-sectional analysis of socioeconomic determinants of functional disability in rheumatoid arthritis patients: a single-region experience from Saudi Arabia
    Yousef M. Alammari, Albandari M. Alajlan, Khawlah A. Alrashed +10
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Workforce Cost Absorption among Community Health Promoters in Fragmented Maternal Nutrition and Social Protection Systems: A Qualitative Study Across Three Kenyan Settings
    F. M. SIVA, D. Nyatuka, R. de la Harpe
    medRxivPreprintCC BYFull textObstetrics, gynaecology & paediatricsmedRxiv
  4. Anterior Capsule Contrast and Capsulorhexis Geometry Across Visualization Systems in Cataract Surgery: An Exploratory Image-Based Comparison
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Unclear source of gastrointestinal bleeding: Utilizing small bowel capsule to detect an enteric duplication cyst, a case report
    Victoria Sarata, Kathryn Clarkston, Kirby Lampe
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{aldawood2026vitro,
  title = {{In vitro and in vivo functional roles of three region 1 promoters in Escherichia coli K1 capsule gene cluster.}},
  author = {Esraa Aldawood and Ian S Roberts},
  journal = {Microbiology (Reading, England)},
  year = {2026},
  month = oct,
  doi = {10.1099/mic.0.001783},
  url = {https://europepmc.org/article/MED/42848660},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - In vitro and in vivo functional roles of three region 1 promoters in Escherichia coli K1 capsule gene cluster.
AU  - Esraa Aldawood
AU  - Ian S Roberts
PY  - 2026
DA  - 2026/10/01
JO  - Microbiology (Reading, England)
DO  - 10.1099/mic.0.001783
UR  - https://europepmc.org/article/MED/42848660
AB  - Capsular polysaccharides are key virulence determinants in extraintestinal pathogenic Escherichia coli, protecting bacteria from host immune defences while modulating interactions with host tissues. In group 2 capsule gene clusters, transcription of region 1 genes required for capsule export is controlled by a complex regulatory region (PR1) containing three tandem promoters (PR1-1, PR1-2 and PR1-3).In this study, targeted mutations were introduced into the -10 elements of each PR1 promoter in the uropathogenic strain UTI89. Transcriptional output from the PR1 region was assessed using a chromosomal PR1-lacZ fusion, and capsule expression was evaluated by K1 bacteriophage sensitivity assays, flow cytometry and immunofluorescence microscopy. Growth in Lysogeny Broth medium demonstrated that all three promoters contributed to capsule expression in vitro, with expression from both PR1-2 and PR1-3 being dependent on a functional upstream PR1-1.In contrast, infection of PD07i bladder epithelial cells revealed a distinct regulatory pattern in which, following invasion, intracellular capsule expression was restored in the absence of PR1-1 and PR1-2, indicating that PR1-3 was sufficient for capsule induction within bladder cells. The presence of a predicted binding site for the oxygen-responsive regulator fumarate and nitrate reduction regulatory protein near PR1-3 suggests a possible mechanism for intracellular activation of PR1-3 under microaerobic host conditions in the absence of a functional PR1-1 promoter.Together, these findings reveal a niche-dependent, multi-promoter regulatory architecture that enables adaptive control of capsule expression during infection.
SN  - 1350-0872
SN  - 1465-2080
ER  -